Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.57 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.57 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.57 |
| ▸ | BCHE | P06276 | 4/20 | 0.54 |
| ▸ | ANPEP | P15144 | 1/20 | 0.49 |
| ▸ | MEN1 | O00255 | 2/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.48 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.48 |
| ▸ | BACE1 | P56817 | 2/20 | 0.48 |
| ▸ | SLC6A11 | P48066 | 1/20 | 0.48 |
| ▸ | DNM1 | Q05193 | 1/20 | 0.47 |
| ▸ | LMNA | P02545 | 1/20 | 0.47 |
| ▸ | MAPT | P10636 | 1/20 | 0.46 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14015766 | 0.89 | ALDH1A1 (0.54) | ALDH1A1CYP1A2CYP2D6BCHEANPEP | |
| SCHEMBL4403903 | 0.89 | ALDH1A1 (0.57) | ALDH1A1CYP1A2CYP2D6BCHEANPEP | |
| SCHEMBL7095555 | 0.88 | BCHE (0.60) | ALDH1A1CYP1A2CYP2D6BCHEANPEP | |
| SCHEMBL7089480 | 0.88 | BCHE (0.60) | ALDH1A1CYP1A2CYP2D6BCHEANPEP | |
| SCHEMBL4530301 | 0.84 | ALDH1A1 (0.77) | ALDH1A1CYP1A2CYP2D6BCHEANPEP | |
| SCHEMBL1849659 | 0.84 | ALDH1A1 (0.77) | ALDH1A1CYP1A2CYP2D6BCHEANPEP | |
| SCHEMBL1325867 | 0.84 | ALDH1A1 (0.77) | ALDH1A1CYP1A2CYP2D6BCHEANPEP | |
| SCHEMBL14015728 | 0.84 | BCHE (0.57) | ALDH1A1CYP1A2CYP2D6BCHEBACE1 | |
| Hydrochloric Acid SCHEMBL6993232 | 0.82 | ALDH1A1 (0.80) | ALDH1A1CYP1A2CYP2D6BCHEANPEP | |
| Hydrochloric Acid SCHEMBL4676912 | 0.82 | ALDH1A1 (0.80) | ALDH1A1CYP1A2CYP2D6BCHEANPEP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250263408-A1 | SPLEEN TYROSINE KINASE INHIBITORS | UNIQUEST PTY LTD (AU) | 2025-08-21 | — | — | US | disclosed |
| CN-119325474-A | Spleen tyrosine kinase inhibitors | 尤尼奎斯特公司 | 2025-01-17 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250263408-A1 | SPLEEN TYROSINE KINASE INHIBITORS | LCK, BTK, SYK | ALDH1A1 3003/4885CYP1A2 930/4885CYP2D6 1001/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.